Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Blood Cells Mol Dis. 2012 Nov 11;50(2):99–104. doi: 10.1016/j.bcmd.2012.10.006

Figure 1. Doses of deferoxamine and deferasirox.

Figure 1

The median and range of doses of DFO (a) and DFX (b) at baseline, 6 months and end of therapy for group A (open symbols, n=7) and B (solid symbols, n=11). The average daily dose of DFO is shown in Figure 1a.